Antimetabolites

DROXIA 6335 DROXIA 6335 Pill - green capsule-shape, 16mm

Generic Name: hydroxyurea

Pill with imprint DROXIA 6335 DROXIA 6335 is Green, Capsule-shape and has been identified as Droxia 200 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of Anemia, Sickle Cell; Solid Tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6335 DROXIA 6335-200 mg-Green-Capsule-shape
Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6335 DROXIA 6335-200 mg-Green-Capsule-shape
Droxia (Hydroxyurea [ hye-drox-ee-yoo-ree-a ])-DROXIA 6335 DROXIA 6335-200 mg-Green-Capsule-shape

Droxia
Generic Name: hydroxyurea [ hye-drox-ee-yoo-ree-a ]
Imprint: DROXIA 6335 DROXIA 6335
Strength: 200 mg
Color: Green
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antimetabolites
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-6335
Inactive Ingredients: Citric acid monohydrate, Gelatin, Magnesium stearate, Sodium phosphate, Titanium dioxide, FD&C Blue No. 1, FD&C Green No. 3,
Latest News
Related Drugs